Literature DB >> 23849567

Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.

Min Chul Cho1, Jung Kwon Kim, Kyung Chul Moon, Hyeon Hoe Kim, Cheol Kwak.   

Abstract

PURPOSE: To study the surgical outcomes of radical nephrectomy with thrombectomy and to determine prognostic factors for survival of Korean patients with renal cell carcinoma (RCC) and venous tumor thrombus.
MATERIALS AND METHODS: A total of 124 patients with RCC and venous tumor thrombus who underwent radical nephrectomy and thrombectomy were included in this retrospective study. Cancer-specific survival (CSS) and recurrence-free survival (RFS) rates were analyzed retrospectively according to various prognostic factors.
RESULTS: The median overall follow-up period for all patients was 29.0 months; the median survival period was 50.0 months. The 2-, 5- and 10-year CSS rates for all patients were 64.2%, 47.1% and 31.7%, respectively. Those for 76 patients (pN0/xM0) without metastasis at presentation were 80.9%, 64.5% and 44.9%, respectively. For all patients, lower body mass index (BMI), higher Fuhrman grade, presence of symptoms, perinephric fat invasion, invasion of inferior vena cava (IVC) wall, lymph node (LN) involvement and distant metastasis at presentation were independent predictors for decreased CSS on multivariate analysis, while thrombus level was not. For non-metastatic patients, lower BMI, presence of symptoms and tumor size were independently associated with decreased CSS. In terms of RFS, lower BMI, presence of perinephric fat invasion were prognostic factors for recurrence.
CONCLUSIONS: Our data suggest that obesity is independently associated with better survival or lower risk of tumor recurrence in Korean patients undergoing radical nephrectomy with tumor thrombectomy. Also, our results indicate that Fuhrman grade, presence of symptoms, perinephric fat invasion and invasion of IVC wall, LN involvement and distant metastasis at presentation are independent predictors for survival.

Entities:  

Mesh:

Year:  2013        PMID: 23849567     DOI: 10.1590/S1677-5538.IBJU.2013.03.08

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  7 in total

1.  Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters.

Authors:  Christian Niedworok; Bettina Dörrenhaus; Frank Vom Dorp; Jarowit Adam Piotrowski; Stephan Tschirdewahn; Tibor Szarvas; Herbert Rübben; Marcus Schenck
Journal:  World J Urol       Date:  2014-11-30       Impact factor: 4.226

Review 2.  Epidemiology and staging of renal cell carcinoma.

Authors:  Carole A Ridge; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

3.  Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.

Authors:  Xiaonan Chen; Shijie Li; Zhenqun Xu; Kefeng Wang; Donghui Fu; Qiang Liu; Xia Wang; Bin Wu
Journal:  World J Surg Oncol       Date:  2015-02-04       Impact factor: 2.754

4.  Preoperative Gamma-Glutamyltransferase Is Associated with Cancer-Specific Survival and Recurrence-Free Survival of Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.

Authors:  Cheng Luo; Ben Xu; Yu Fan; Wei Yu; Qian Zhang; Jie Jin
Journal:  Biomed Res Int       Date:  2017-01-11       Impact factor: 3.411

5.  Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus.

Authors:  Bingqing Shang; Liping Guo; Rongfang Shen; Chuanzhen Cao; Ruiyang Xie; Weixing Jiang; Li Wen; Xingang Bi; Hongzhe Shi; Shan Zheng; Changling Li; Jianhui Ma; Kaitai Zhang; Lin Feng; Jianzhong Shou
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

6.  Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience.

Authors:  Mathisekaran Thangarasu; J Sanjay Prakash; Sandeep Bafna; P Aarthy; Thirumalai Ganesan Govindaswamy; Balaji Venugopal; Ananthakrishnan Sivaraman; Nitesh Jain; Arunkumar Balakrishnan; Deepak Raghavan; Murali Venkatraman; M Chandranathan; Rajesh Paul; Nivash Selvaraj; Balasubramaniam Ramakrishnan; Narasimhan Ragavan
Journal:  Urol Ann       Date:  2022-07-18

7.  Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI.

Authors:  Lisa C Adams; Bernhard Ralla; Yi-Na Y Bender; Keno Bressem; Bernd Hamm; Jonas Busch; Florian Fuller; Marcus R Makowski
Journal:  Cancer Imaging       Date:  2018-05-03       Impact factor: 3.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.